KCNJ5 and primary aldosteronism: Another study on patients with primary aldosteronism uncovered that KCNJ5 mutations were associated with higher baseline PHQ scores and a better response to treatment with adrenalectomy, indicating that KCNJ5 mutations may participate in the formation of depressive symptoms (42).